Insights from a Physician-Led Practice

Thousands of patients are blindsided when GLP-1 savings cards expire, get pulled, or change terms.

A physician's analysis of the $1.8 billion AI telehealth company built on deepfaked patients, fabricated doctors, and FDA violations.

Mislabeled vials, teenage users, necrotizing pancreatitis — a physician's harsh take on the social media peptide underground.

A transparent look at which therapies have strong clinical evidence, which show promise, and which are pure hype.

Retatrutide, orforglipron, amycretin — the next wave of weight loss medications is showing remarkable results in trials.

The "research use only" label is a legal loophole, not a quality standard. Here's what you need to know about purity and contamination.

Why the source of your peptides matters as much as the peptide itself.

Cutting through the hype — what 36 studies tell us about BPC-157's potential for healing, recovery, and gut health.

A physician's honest comparison of compounded tirzepatide and the brand-name version.

A week-by-week guide to starting tirzepatide or semaglutide — what's normal, what's not, and when to contact your physician.